Investigating the Prevalence of COVID-19 In A Deprived Area Using Diagnostic Tests: A Cross-Sectional Study Reflecting Capability of Jihadi and Military Forces

Document Type : Original Research

Authors

1 Chemical Injuries Research Center, Systems Biology and Poisoning Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

2 Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran

3 Student Research Committee and Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background and Aim: Corona antibody testing is one of the common methods used for diagnosing coronavirus infection due to its low cost, easy access, short testing time, and convenient sampling. Iran, with its valuable Jihadi and military resources, has been able to take some effective steps in controlling the crisis caused by this disease. This is especially important in disadvantaged and underprivileged areas. The present study aimed at investigating the prevalence of Covid-19 among people living around Hamun Lake, Sistan and Baluchestan, Iran, using serological tests while considering the access to medical and healthcare facilities.
Methods: This cross-sectional study was conducted by collecting data through administering a face-to-face checklist among people living in Hamun Lake, Sistan and Baluchestan, Iran in March 2021. The checklist included the demographic data, symptoms, and underlying diseases. Laboratory and serological test data including PCR, IgM, and IgG tests were also evaluated. This study was carried out with the help of Jihadi and military forces.
Results: According to the IgM and IgG diagnostic tests performed in this study, out of 622 patients, 74 were IgM positive and 105 were IgG positive. Besides, 10 participants were positive for all antigens. People over the age of 30 were significantly more likely to be diagnosed with the disease. However, there was no significant difference between men and women although women were more diagnosed with COVID-19. The most common symptoms associated with the disease in this study were cough (12%), shortness of breath (8%), and body pain (6%). Blood pressure (13%), heart diseases (9%), and diabetes (8%) were the predominant underlying diseases in the participants.
Conclusion: The findings of this study indicated that the prevalence of coronavirus disease in Hamun Lake, one of the deprived areas of the country in terms of access to healthcare facilities, was not significantly different compared to other parts of the country. It can be concluded that the level of access to healthcare facilities, cannot be one of the factors affecting the prevalence and incidence of coronavirus disease, at least in this study. The present study revealed the successful experience of using military forces to help the underprivileged people of the country to manage the pandemic outbreak of coronavirus disease.

Keywords

References

1. Peiris JS, Yuen KY, Osterhaus AD and Stöhr K. The severe acute respiratory syndrome. New England Journal of Medicine. 2003; 349(25): 2431-41. DOI: 10.1056/NEJMra032498 2. Mijović B. COVID-19: Lessons learned. Scripta Medica. 2020; 51(1): 1-5. DOI: 10.5937/scriptamed51-25824 3. Rothan HA and Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity. 2020; 109(102433). DOI: 10.1016/j.jaut.2020.102433 4. Sarkarat F, Tootoonchian A, Haraji A, Rastegarmoghaddam Shaldoozi H, Mostafavi M and Naghibi Sistani SMM. Evaluation of dentistry staff involvement with COVID-19 in the first 3 month of epidemiologic spreading in Iran. journal of research in dental sciences. 2020; 17(2): 137-45. DOI: 10.29252/jrds.17.2.137 [In Persian] 5. Wang C, Horby PW, Hayden FG and Gao GF. A novel coronavirus outbreak of global health concern. The lancet. 2020; 395(10223): 470-3. DOI:https://doi.org/10.1016/S0140-6736(20)30185-9 6. Ahmadikia K, Mahmoudi S, Hassanali F, Keshavarz M, Mirhendi H and Malekzadeh E. A Review on the diagnostic approaches of COVID-19 infection; Features and limitations. Journal of Isfahan Medical School. 2021; 39(611): . DOI: 10.22122/jims.v39i611.13023 [In Persian] 7. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y and Xia J. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine. 2020; 382(12): 1177-9. DOI: 10.1056/NEJMc2001737 8. Gholipour S, Shamsizadeh Z, Moazeni M and Nikaeen M. Environmental aspects of the coronaviruses transmission: A narrative review. Journal of Isfahan Medical School. 2020; 38(570): . DOI: 10.22122/jims.v38i570.12893 [In Persian] 9. Tré-Hardy M, Blairon L, Wilmet A, Beukinga I, Malonne H, Dogné J-M and Douxfils J. The role of serology for COVID-19 control: Population, kinetics and test performance do matter. The Journal of infection. 2020; 81(2): e91-e2. DOI: 10.1016/j.jinf.2020.05.019 10. Cai X-f, Chen J, li Hu J-, Long Q-x, Deng H-j, Liu P, Fan K, Liao P, Liu B-z and Wu G-c. A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of coronavirus disease 2019. The Journal of infectious diseases. 2020; 222(2): 189-93. DOI: 10.1093/infdis/jiaa243 11. Mehrian P and Farnia P. The role of computerized tomography scan in diagnosis and management of coronavirus disease 2019 (COVID-19). Journal of Isfahan Medical School. 2020; 38(578): . DOI: 10.22122/jims.v38i578.13080 [In Persian] 12. Gad M, Kazibwe J, Quirk E, Gheorghe A, Homan Z and Bricknell M. Civil-military cooperation in the early response to the COVID-19 pandemic in six European countries. 2021; 167(4): 234-43. DOI:10.1136/bmjmilitary-2020-001721 13. Farnoosh G, Alishiri G, Hosseini Zijoud S, Dorostkar R and Jalali Farahani A. Understanding the 2019-novel coronavirus (2019-nCoV) and coronavirus disease (COVID-19) based on available evidence-a narrative review. J Mil Med. 2020; 22(1): 1-11. DOI: 10.30491/JMM.22.1.1 [In Persian] 14. Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, Eslami S, Javanmard SH, Shakiba E and Somi MH. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. The Lancet Infectious Diseases. 2021; 21(4): 473-81. DOI: 10.1016/S1473-3099(20)30858-6 15. Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M and Qazvini A. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. Journal of Clinical Virology. 2020; 127(104378). DOI: 10.1016/j.jcv.2020.104378 16. Ghafari M, Kadivar A and Katzourakis A. Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis. Int J Infect Dis. 2021; 107(101-15). https://doi.org/10.1016/j.ijid.2021.04.015 17. Shakiba M, Nazemipour M, Heidarzadeh A and Mansournia MA. Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey. Epidemiology and Infection. 2020; 148(e300). DOI: 10.1017/S0950268820002745 18. Ceylan Z. Estimation of COVID-19 prevalence in Italy, Spain, and France. Science of The Total Environment. 2020; 729(138817). https://doi.org/10.1016/j.scitotenv.2020.138817 19. Farnoosh G, Ghanei M, Khorramdelazad H, Alishiri G, Farahani AJ, Shahriary A and Zijoud SRH. Are Iranian sulfur mustard gas-exposed survivors more vulnerable to SARS-CoV-2? Some similarity in their pathogenesis. Disaster medicine and public health preparedness. 2020; 14(6): 826-32. DOI: 10.1017/dmp.2020.156. 20. Xie Y, Wang X, Yang P and Zhang S. COVID-19 complicated by acute pulmonary embolism. Radiology: Cardiothoracic Imaging. 2020; 2(2): e200067. https://doi.org/10.1148/ryct.2020200067 21. Casey K, Iteen A, Nicolini R and Auten J. COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. The American journal of emergency medicine. 2020; 38(7): 1544. DOI: 10.1016/j.ajem.2020.04.011 22. Ran J, Song Y, Zhuang Z, Han L, Zhao S, Cao P, Geng Y, Xu L, Qin J and He D. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertension Research. 2020; 43(11): 1267-76. https://doi.org/10.1038/s41440-020-00541-w 23. Hosseini A, Ghaleh HEG, Aghamollaei H, Ramandi MF, Alishiri G, Shahriary A, Hassanpour K, Tat M and Farnoosh G. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment. European Journal of Pharmacology. 2021; 904(174193). DOI: 10.1016/j.ejphar.2021.174193 24. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z and Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology. 2020; 109(5): 531-8. DOI: 10.1007/s00392-020-01626-9.
Journal of Military Medicine
Volume 24, Issue 1 - Serial Number 110
March and April 2022
Pages 1016-1023

Files

Share

How to cite

Statistics